NDC product
Miconazole Nitrate Antifungal Powder
NDC 10135-720 · Marlex Pharmaceuticals, Inc.
Key facts
| Product NDC | 10135-720 |
|---|---|
| Proprietary name | Miconazole Nitrate Antifungal Powder |
| Nonproprietary name | Miconazole Nitrate Antifungal Powder |
| Substances | MICONAZOLE NITRATE |
| Dosage form | POWDER |
| Route | TOPICAL |
| Labeler | Marlex Pharmaceuticals, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M005 |
| Pharmacologic classes | Azole Antifungal [EPC], Azoles [CS] |
| Marketing start | May 1, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: